January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21. The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]
Search Results for: NEW
Press Release
OPKO Health’s BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
04
Jan
Jan
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]
Press Release
Buffalo Bills and OPKO Health’s BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
31
Dec
Dec
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]
29
Dec
Dec
This past year has been one of uncertainty and many people’s lives have changed drastically over the course of nine months. While maintaining social distancing and stay at home orders, routine health has taken a back seat to protecting ourselves and each other from infection. As we wrap up the holidays and enter into a […]
Press Release
Auth0 and BioReference Laboratories Answer Patient Demand for Secure, Direct Access to Test Results
10
Dec
Dec
Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec. 10, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that it is providing BioReference Laboratories, Inc., an OPKO Health company and a leading provider of laboratory testing services in the U.S., with […]
03
Dec
Dec
We are excited to announce that BioReference Laboratories now supports test results through Health Records on iPhone in the Apple Health app.* The Health Records feature makes it easy to see a central view of your health records from multiple providers whenever you choose, including your lab results. Getting your BioReference test results into your […]
Press Release
OPKO Health’s BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
20
Oct
Oct
New offering identifies COVID-19 and Influenza infections with a single sample ELMWOOD PARK, N.J., October 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the […]
Mad Money with Jim Cramer BioReference Laboratories Executive Chairman Jon Cohen gives an update on coronavirus testing in the NBA and NFL, clearing the air behind so-called “false positive” diagnoses in football. Click here for original post on Mad Money with Jim Cramer
06
Oct
Oct
Every October, we are surrounded by a sea of pink to inspire hope and raise awareness of breast cancer. The month is dedicated to educating the public about breast cancer early detection, causes, prevention, treatment, support services and more. According to the American Cancer Society, breast cancer is the second most common cancer in American […]
15
Sep
Sep
September is Prostate Cancer Awareness Month, a time to raise awareness about the risks of prostate cancer and encourage men to take control of their prostate health by getting their regular screenings. Prostate cancer is one of the most common cancers found in American men, second only to skin cancer. In 2020, the American Cancer […]
